CELCUITY INC (CELC) Fundamental Analysis & Valuation

NASDAQ:CELC • US15102K1007

Current stock price

125.65 USD
+4.3 (+3.54%)
At close:
147.56 USD
+21.91 (+17.44%)
Pre-Market:

This CELC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CELC Profitability Analysis

1.1 Basic Checks

  • CELC had negative earnings in the past year.
  • In the past year CELC has reported a negative cash flow from operations.
  • CELC had negative earnings in each of the past 5 years.
  • CELC had a negative operating cash flow in each of the past 5 years.
CELC Yearly Net Income VS EBIT VS OCF VS FCFCELC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -37.95%, CELC is in line with its industry, outperforming 56.16% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -176.06%, CELC is doing worse than 68.88% of the companies in the same industry.
Industry RankSector Rank
ROA -37.95%
ROE -176.06%
ROIC N/A
ROA(3y)-38.97%
ROA(5y)-34.87%
ROE(3y)-106.12%
ROE(5y)-78.33%
ROIC(3y)N/A
ROIC(5y)N/A
CELC Yearly ROA, ROE, ROICCELC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CELC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CELC Yearly Profit, Operating, Gross MarginsCELC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CELC Health Analysis

2.1 Basic Checks

  • CELC has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CELC has more shares outstanding
  • The debt/assets ratio for CELC is higher compared to a year ago.
CELC Yearly Shares OutstandingCELC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CELC Yearly Total Debt VS Total AssetsCELC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • CELC has an Altman-Z score of 8.48. This indicates that CELC is financially healthy and has little risk of bankruptcy at the moment.
  • CELC's Altman-Z score of 8.48 is fine compared to the rest of the industry. CELC outperforms 79.26% of its industry peers.
  • CELC has a Debt/Equity ratio of 3.20. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CELC (3.20) is worse than 81.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Altman-Z 8.48
ROIC/WACCN/A
WACCN/A
CELC Yearly LT Debt VS Equity VS FCFCELC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 10.55 indicates that CELC has no problem at all paying its short term obligations.
  • CELC's Current ratio of 10.55 is amongst the best of the industry. CELC outperforms 81.60% of its industry peers.
  • CELC has a Quick Ratio of 10.55. This indicates that CELC is financially healthy and has no problem in meeting its short term obligations.
  • CELC has a Quick ratio of 10.55. This is amongst the best in the industry. CELC outperforms 81.60% of its industry peers.
Industry RankSector Rank
Current Ratio 10.55
Quick Ratio 10.55
CELC Yearly Current Assets VS Current LiabilitesCELC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CELC Growth Analysis

3.1 Past

  • CELC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.88%.
EPS 1Y (TTM)-34.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.12%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • CELC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.20% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.66%
EPS Next 2Y37.98%
EPS Next 3Y44.41%
EPS Next 5Y34.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CELC Yearly Revenue VS EstimatesCELC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
CELC Yearly EPS VS EstimatesCELC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

1

4. CELC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CELC. In the last year negative earnings were reported.
  • Also next year CELC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CELC Price Earnings VS Forward Price EarningsCELC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CELC Per share dataCELC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 -3

4.3 Compensation for Growth

  • CELC's earnings are expected to grow with 44.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.98%
EPS Next 3Y44.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CELC Dividend Analysis

5.1 Amount

  • No dividends for CELC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CELC Fundamentals: All Metrics, Ratios and Statistics

CELCUITY INC

NASDAQ:CELC (5/1/2026, 8:14:58 PM)

Premarket: 147.56 +21.91 (+17.44%)

125.65

+4.3 (+3.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength54.04
Industry Growth13.66
Earnings (Last)03-25
Earnings (Next)05-18
Inst Owners91.16%
Inst Owner Change-1.96%
Ins Owners9.5%
Ins Owner Change-0.35%
Market Cap6.07B
Revenue(TTM)N/A
Net Income(TTM)-177.04M
Analysts85.88
Price Target133.16 (5.98%)
Short Float %21.99%
Short Ratio12.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.66%
Min EPS beat(2)8.73%
Max EPS beat(2)10.59%
EPS beat(4)3
Avg EPS beat(4)1.54%
Min EPS beat(4)-15.3%
Max EPS beat(4)10.59%
EPS beat(8)5
Avg EPS beat(8)0.66%
EPS beat(12)6
Avg EPS beat(12)-1.16%
EPS beat(16)6
Avg EPS beat(16)-7.71%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.39%
PT rev (3m)18.14%
EPS NQ rev (1m)-2.58%
EPS NQ rev (3m)-1.08%
EPS NY rev (1m)6.51%
EPS NY rev (3m)6.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.91%
Revenue NY rev (3m)11.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 60.4
P/tB 60.4
EV/EBITDA N/A
EPS(TTM)-3.79
EYN/A
EPS(NY)-3.89
Fwd EYN/A
FCF(TTM)-3.18
FCFYN/A
OCF(TTM)-3.17
OCFYN/A
SpS0
BVpS2.08
TBVpS2.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -37.95%
ROE -176.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.97%
ROA(5y)-34.87%
ROE(3y)-106.12%
ROE(5y)-78.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 149.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.55
Quick Ratio 10.55
Altman-Z 8.48
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)136.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.12%
EPS Next Y-2.66%
EPS Next 2Y37.98%
EPS Next 3Y44.41%
EPS Next 5Y34.2%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-30.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.64%
OCF growth 3YN/A
OCF growth 5YN/A

CELCUITY INC / CELC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CELCUITY INC (CELC) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CELC.


Can you provide the valuation status for CELCUITY INC?

ChartMill assigns a valuation rating of 1 / 10 to CELCUITY INC (CELC). This can be considered as Overvalued.


What is the profitability of CELC stock?

CELCUITY INC (CELC) has a profitability rating of 0 / 10.


How financially healthy is CELCUITY INC?

The financial health rating of CELCUITY INC (CELC) is 5 / 10.